Latest News

2024.03.14

Innovative Patented In Vitro Diagnostics Receives Market Approval
2024.02.17

World Premiere: Leadgene Biomedical's Indoxyl Sulfate (IS) ELISA Kit Secures TFDA Approval
2024.01.22

Leadgene Biomedical Embraces Openness and Strategic Partnerships for Global Market Expansion
2023.12.25

Nanobody Development: Pioneering Tiny Titans for Next-Generation Biotechnology
2023.11.02

Leadgene Biomedical Achieves Recognition as a Domestic CRO Service Company!
2023.10.03

Leadgene Biomedical CEO Honored with 2023 Best Bio CEO Second Prize & Best Potential Prize
2023.09.06

Leadgene Biomedical Wins 2023 Taipei Biotech Awards - Innovation Special Mention Awards
2023.08.11

Leadgene Biomedical Achieves Milestone Recognition, Paving the Way for Advanced Kidney Disease Diagnostics in Taiwan
2023.07.24

Leadgene Biomedical, Inc. Aims for IPO within Three Years Driven by Reagent Raw Materials and Uremic Toxin Detection Kit
2023.04.27

Indoxyl Sulfate Antibody Secures Second U.S. Patent
2023.03.13

Leadgene Indoxyl Sulfate ELISA Kit Helps Medical Institutions Seize the Golden Treatment Period for Kidney Disease
2022.11.10

31st National Award of Outstanding SMEs Awarded!